The grant to Kleo Pharmaceuticals will support efforts to advance development of a COVID-19 hyperimmune globulin mimic therapeutic that could provide a synthetic, homogenous, readily available replacement for convalescent serum, which has shown promise as a treatment for COVID-19….
Philanthropy News Digest | https://philanthropynewsdigest.org/rss/feed/pndnewsKeMeK Philanthropy
Philanthropy, Action, Charitable Causes
